These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 37086891

  • 21. In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates.
    Findlay J, Poirel L, Nordmann P.
    J Glob Antimicrob Resist; 2023 Mar; 32():66-71. PubMed ID: 36649860
    [Abstract] [Full Text] [Related]

  • 22. Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.
    Gaibani P, Re MC, Campoli C, Viale PL, Ambretti S.
    Clin Microbiol Infect; 2020 Apr; 26(4):516.e1-516.e4. PubMed ID: 31740422
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R, Petraitis V, Kavaliauskas P, Maung BBW, Khan F, Naing E, Aung T, Zigmantaite V, Grigaleviciute R, Kucinskas A, Stakauskas R, Georgiades BN, Mazur CA, Hayden JA, Satlin MJ, Walsh TJ.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015048
    [Abstract] [Full Text] [Related]

  • 24. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae.
    Ojdana D, Gutowska A, Sacha P, Majewski P, Wieczorek P, Tryniszewska E.
    Microb Drug Resist; 2019 Nov 24; 25(9):1357-1364. PubMed ID: 31295055
    [Abstract] [Full Text] [Related]

  • 25. The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria.
    Plazak ME, Tamma PD, Heil EL.
    Expert Opin Pharmacother; 2018 Dec 24; 19(18):2019-2031. PubMed ID: 30346216
    [Abstract] [Full Text] [Related]

  • 26. Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.
    Shen S, Tang C, Ding L, Han R, Yin D, Yang W, Guo Y, Hu F.
    mSphere; 2022 Dec 21; 7(6):e0048722. PubMed ID: 36374086
    [Abstract] [Full Text] [Related]

  • 27. In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam.
    Guzmán-Puche J, Pérez-Nadales E, Pérez-Vázquez M, Causse M, Gracia-Ahufinger I, Mendez-Natera A, Allalou-Ruiz Y, Elías C, Oteo-Iglesias J, Torre-Cisneros J, Martínez-Martínez L.
    Int J Antimicrob Agents; 2022 Feb 21; 59(2):106524. PubMed ID: 35038557
    [Abstract] [Full Text] [Related]

  • 28. Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study.
    Tumbarello M, Raffaelli F, Cascio A, Falcone M, Signorini L, Mussini C, De Rosa FG, Losito AR, De Pascale G, Pascale R, Giacobbe DR, Oliva A, Farese A, Morelli P, Tiseo G, Meschiari M, Del Giacomo P, Montagnani F, Fabbiani M, Vargas J, Spanu T, Bassetti M, Venditti M, Viale P.
    JAC Antimicrob Resist; 2022 Mar 21; 4(1):dlac022. PubMed ID: 35265842
    [Abstract] [Full Text] [Related]

  • 29. Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Li X, Ke H, Wu W, Tu Y, Zhou H, Yu Y.
    mSphere; 2021 Dec 22; 6(6):e0085921. PubMed ID: 34935448
    [Abstract] [Full Text] [Related]

  • 30. Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin.
    Boattini M, Bianco G, Iannaccone M, Bondi A, Cavallo R, Costa C.
    J Chemother; 2021 Dec 22; 33(8):598-600. PubMed ID: 33843501
    [No Abstract] [Full Text] [Related]

  • 31. Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC β-Lactamase.
    Taracila MA, Bethel CR, Hujer AM, Papp-Wallace KM, Barnes MD, Rutter JD, VanPelt J, Shurina BA, van den Akker F, Clancy CJ, Nguyen MH, Cheng S, Shields RK, Page RC, Bonomo RA.
    Antimicrob Agents Chemother; 2022 Apr 19; 66(4):e0212421. PubMed ID: 35311523
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.
    Kang Y, Zhou Q, Cui J.
    J Glob Antimicrob Resist; 2021 Dec 19; 27():67-71. PubMed ID: 34428596
    [Abstract] [Full Text] [Related]

  • 33. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
    Maraki S, Mavromanolaki VE, Magkafouraki E, Moraitis P, Stafylaki D, Kasimati A, Scoulica E.
    Infection; 2022 Apr 19; 50(2):467-474. PubMed ID: 34854060
    [Abstract] [Full Text] [Related]

  • 34. A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring blaKPC-14 Isolated in New York City.
    Niu S, Chavda KD, Wei J, Zou C, Marshall SH, Dhawan P, Wang D, Bonomo RA, Kreiswirth BN, Chen L.
    mSphere; 2020 Aug 26; 5(4):. PubMed ID: 32848008
    [Abstract] [Full Text] [Related]

  • 35. Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
    Bianco G, Boattini M, Comini S, Casale R, Iannaccone M, Cavallo R, Costa C.
    Eur J Clin Microbiol Infect Dis; 2022 Apr 26; 41(4):573-580. PubMed ID: 35061145
    [Abstract] [Full Text] [Related]

  • 36. Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report.
    Arcari G, Oliva A, Sacco F, Di Lella FM, Raponi G, Tomolillo D, Curtolo A, Venditti M, Carattoli A.
    Eur J Clin Microbiol Infect Dis; 2022 Mar 26; 41(3):495-500. PubMed ID: 34988712
    [Abstract] [Full Text] [Related]

  • 37. Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions.
    Bongiorno D, Bivona DA, Cicino C, Trecarichi EM, Russo A, Marascio N, Mezzatesta ML, Musso N, Privitera GF, Quirino A, Scarlata GGM, Matera G, Torti C, Stefani S.
    Front Cell Infect Microbiol; 2022 Mar 26; 12():1010979. PubMed ID: 36683697
    [Abstract] [Full Text] [Related]

  • 38. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M, Castillo-Polo JA, Cordero DG, Pérez-Viso B, García-Castillo M, Saez de la Fuente J, Morosini MI, Cantón R, Ruiz-Garbajosa P.
    J Clin Microbiol; 2022 Mar 16; 60(3):e0224521. PubMed ID: 35107303
    [Abstract] [Full Text] [Related]

  • 39. Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series.
    van Asten SAV, Boattini M, Kraakman MEM, Bianco G, Iannaccone M, Costa C, Cavallo R, Bernards AT.
    J Infect Chemother; 2021 May 16; 27(5):778-780. PubMed ID: 33558042
    [Abstract] [Full Text] [Related]

  • 40. Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature.
    Cano Á, Guzmán-Puche J, García-Gutiérrez M, Castón JJ, Gracia-Ahufinger I, Pérez-Nadales E, Recio M, Natera AM, Marfil-Pérez E, Martínez-Martínez L, Torre-Cisneros J.
    J Glob Antimicrob Resist; 2020 Sep 16; 22():9-12. PubMed ID: 31733412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.